Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
S Verma, ME Farkouh, B Yanagawa… - The lancet Diabetes & …, 2013 - thelancet.com
Background The choice between coronary artery bypass surgery (CABG) and percutaneous
coronary intervention (PCI) for revascularisation in patients with diabetes and multivessel …
coronary intervention (PCI) for revascularisation in patients with diabetes and multivessel …
Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside
J Nicolas, CA Pivato, M Chiarito… - Cardiovascular …, 2023 - academic.oup.com
Coronary stents have revolutionized the treatment of coronary artery disease. Compared
with balloon angioplasty, bare-metal stents (BMSs) effectively prevented abrupt vessel …
with balloon angioplasty, bare-metal stents (BMSs) effectively prevented abrupt vessel …
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery
DM Bravata, AL Gienger, KM McDonald… - Annals of internal …, 2007 - acpjournals.org
Background: The comparative effectiveness of coronary artery bypass graft (CABG) surgery
and percutaneous coronary intervention (PCI) for patients in whom both procedures are …
and percutaneous coronary intervention (PCI) for patients in whom both procedures are …
The final 10-year follow-up results from the BARI randomized trial
BARI Investigators⁎⁎ - Journal of the American College of Cardiology, 2007 - jacc.org
Objectives: We sought to compare 10-year clinical outcomes in the BARI (Bypass
Angioplasty Revascularization Investigation) trial patients who were randomly assigned to …
Angioplasty Revascularization Investigation) trial patients who were randomly assigned to …
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease
GBJ Mancini, G Gosselin, B Chow, W Kostuk… - Canadian Journal of …, 2014 - Elsevier
This overview provides a guideline for the management of stable ischemic heart disease. It
represents the work of a primary and secondary panel of participants from across Canada …
represents the work of a primary and secondary panel of participants from across Canada …
Diabetes and coronary revascularization
JD Flaherty, CJ Davidson - Jama, 2005 - jamanetwork.com
ContextPatients with diabetes mellitus account for approximately 25% of the nearly 1.5
million coronary revascularization procedures performed each year in the United States and …
million coronary revascularization procedures performed each year in the United States and …
Coronary heart disease in patients with diabetes: part I: recent advances in prevention and noninvasive management
C Berry, JC Tardif, MG Bourassa - Journal of the American College of …, 2007 - jacc.org
Diabetes mellitus (DM) is a worldwide epidemic. Its prevalence is rapidly increasing in both
developing and developed countries. Coronary heart disease (CHD) is highly prevalent and …
developing and developed countries. Coronary heart disease (CHD) is highly prevalent and …
Long-term survival after surgical or percutaneous revascularization in patients with diabetes and multivessel coronary disease
Background There remains a paucity of real-world observational evidence comparing
percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in …
percutaneous coronary intervention (PCI) with coronary artery bypass grafting (CABG) in …
Five-year follow-up after sirolimus-eluting stent implantation: results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) trial
G Weisz, MB Leon, DR Holmes, DJ Kereiakes… - Journal of the American …, 2009 - jacc.org
Objectives: The aim of this study was to examine the 5-year clinical safety and efficacy
outcomes in patients enrolled in the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native …
outcomes in patients enrolled in the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native …
Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry
J Machecourt, N Danchin, JM Lablanche… - Journal of the American …, 2007 - jacc.org
Objectives: We sought to assess the frequency and causes of stent thrombosis in diabetic
and nondiabetic patients after implantation of sirolimus-eluting stents. Background: Safety …
and nondiabetic patients after implantation of sirolimus-eluting stents. Background: Safety …